Phase 2a Study Evaluating a Chemokine-Modulatory Regimen in Patients With Colorectal Cancer Metastatic to the Liver

Trial Profile

Phase 2a Study Evaluating a Chemokine-Modulatory Regimen in Patients With Colorectal Cancer Metastatic to the Liver

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Feb 2018

At a glance

  • Drugs Celecoxib (Primary) ; Interferon alpha-2b (Primary) ; Rintatolimod (Primary)
  • Indications Colorectal cancer; Liver metastases
  • Focus Pharmacodynamics
  • Most Recent Events

    • 08 Feb 2018 Planned initiation date changed from 1 Feb 2018 to 1 Mar 2018.
    • 22 Jan 2018 Phase has been changed from Phase 0 to Phase 2A.
    • 22 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top